Hegde NR - Search Results

1

COVID-19: A Veterinary and One Health Perspective.

Kumar D, Bayry J, Hegde NR. Kumar D, et al. Among authors: hegde nr. J Indian Inst Sci. 2022;102(2):689-709. doi: 10.1007/s41745-022-00318-9. Epub 2022 Aug 10. J Indian Inst Sci. 2022. PMID: 35968231 Free PMC article. Review.

2

Thermostable foot-and-mouth disease virus as a vaccine candidate for endemic countries: a perspective.

Hegde NR, Maddur MS, Rao PP, Kaveri SV, Bayry J. Hegde NR, et al. Vaccine. 2009 Apr 6;27(16):2199-201. doi: 10.1016/j.vaccine.2009.01.032. Epub 2009 Feb 2. Vaccine. 2009. PMID: 19189856 No abstract available.

3

Reasons to include viruses in the tree of life.

Hegde NR, Maddur MS, Kaveri SV, Bayry J. Hegde NR, et al. Nat Rev Microbiol. 2009 Aug;7(8):615; author reply 615. doi: 10.1038/nrmicro2108-c1. Nat Rev Microbiol. 2009. PMID: 19561628 No abstract available.

4

Immunotherapy of viral infections.

Hegde NR, Rao PP, Bayry J, Kaveri SV. Hegde NR, et al. Immunotherapy. 2009 Jul;1(4):691-711. doi: 10.2217/imt.09.26. Immunotherapy. 2009. PMID: 20635993 Review.

5

Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.

Hegde NR, Kaveri SV, Bayry J. Hegde NR, et al. Drug Discov Today. 2011 Dec;16(23-24):1061-8. doi: 10.1016/j.drudis.2011.07.004. Epub 2011 Jul 18. Drug Discov Today. 2011. PMID: 21782969 Review.

6

Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production.

Kumar D, Beach NM, Meng XJ, Hegde NR. Kumar D, et al. Among authors: hegde nr. J Virol Methods. 2012 Jan;179(1):201-11. doi: 10.1016/j.jviromet.2011.10.017. Epub 2011 Nov 3. J Virol Methods. 2012. PMID: 22079617

7

Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India.

Hegde NR, Kumar D, Rao PP, Kumari PK, Kaushik Y, Ravikrishnan R, Prasad SD, Ella KM. Hegde NR, et al. Vaccine. 2014 Jun 17;32(29):3636-43. doi: 10.1016/j.vaccine.2014.04.072. Epub 2014 May 5. Vaccine. 2014. PMID: 24801052

8

The use of BirA-BAP system to study the effect of US2 and US11 on MHC class I heavy chain in cells.

Gauthami S, Kumar D, SivaSai KSR, Hegde NR. Gauthami S, et al. Among authors: hegde nr. Immunol Lett. 2017 Oct;190:233-239. doi: 10.1016/j.imlet.2017.08.027. Epub 2017 Aug 30. Immunol Lett. 2017. PMID: 28860039

9

The use of databases, data mining and immunoinformatics in vaccinology: where are we?

Hegde NR, Gauthami S, Sampath Kumar HM, Bayry J. Hegde NR, et al. Expert Opin Drug Discov. 2018 Feb;13(2):117-130. doi: 10.1080/17460441.2018.1413088. Epub 2017 Dec 11. Expert Opin Drug Discov. 2018. PMID: 29226722 Review.

10

Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein.

Kumar D, Gauthami S, Uma M, Nagalekshmi K, Rao PP, Basu A, Ella KM, Hegde NR. Kumar D, et al. Among authors: hegde nr. Viral Immunol. 2018 Sep;31(7):500-512. doi: 10.1089/vim.2017.0122. Epub 2018 Aug 10. Viral Immunol. 2018. PMID: 30095362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page